Effect of Risk Factors Likely to Influence Immuno of Combined Hepatitis A & B Vacc vs Monovalent Hepatitis A & B Vacc
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Hepatitis B
Related studies linked through entity extraction aliases.
Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Month Schedule
- Status
- COMPLETED
- Phase
- PHASE3
A Comparison of the Drug Telbivudine (LdT) and Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis.
- Status
- COMPLETED
- Phase
- PHASE3
A Randomized Trial of Vaccine Adherence in Young Injection Drug Users
- Status
- COMPLETED
- Phase
- NA
Long Term Follow-Up Study 16-20 Years After Hepatitis B Vaccination in Newborns of Mothers Who Were Seropositive for Hepatitis B Envelope Antigen (HBeAg) & Hepatitis B Surface Antigen (HBsAg)
- Status
- COMPLETED
- Phase
- PHASE4
LT F-up Study 16-20 Yrs After Vaccine Dose of Hepatitis B With/Without HBIg in Newborns to HBeAg+ Mothers
- Status
- COMPLETED
- Phase
- PHASE4
Follow-up Study 16-20 Years After Primary Vaccination Against Hepatitis B of Newborns From HBeAg+ & HBsAg+ Mothers
- Status
- COMPLETED
- Phase
- PHASE4
Hepsera Versus Hepsera Plus Lamivudine for Treatment of Chronic Hepatitis B in Patients With Normal ALT
- Status
- COMPLETED
- Phase
- PHASE4
Hepatitis B Vaccination in HIV-infected Persons
- Status
- COMPLETED
- Phase
- PHASE4
Safety Study of Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix, and Mencevax ACWY Vaccines in Children
- Status
- COMPLETED
- Phase
- PHASE3
HepeX-B in Post Hepatic Allografts for Treatment of End Stage Liver Disease Due to Hepatitis B Infection
- Status
- TERMINATED
- Phase
- PHASE2
Qidong Hepatitis B Intervention Study
- Status
- COMPLETED
- Phase
- PHASE4
Pilot Safety Study to Determine the Ability of the Protector Cap Jet Injector to Prevent Cross-Contamination
- Status
- COMPLETED
- Phase
- PHASE1
Lot-to-lot Consistency of Tritanrix™-HepB/Hib-MenAC & Its Non-inferiority vs Tritanrix™-HepB/Hiberix™ in Infants
- Status
- COMPLETED
- Phase
- PHASE3
Long Term Follow-up Study at Years 2, 3, 4 and 5 Where 2 Dosing Schedules of the Combined Hepatitis A and B Vaccine Were Compared
- Status
- COMPLETED
- Phase
- PHASE3
Long Term F/U Studies at Y5&6 to Demonstrate the Equivalence of 2 Vaccination Schedules of Combined Hepatitis A & B Vaccine
- Status
- COMPLETED
- Phase
- PHASE3
Comparison of Monodose and Multidose Presentations of GSK Biologicals' Hepatitis B Vaccine in Terms of Immune Response
- Status
- COMPLETED
- Phase
- PHASE4
Long-Term Follow-Up Studies at Year 6, 7, 8, 9, 10: 2 Formulations of Combined Hepatitis A/B Vaccine Compared in Subjects Aged 12-15 Years
- Status
- COMPLETED
- Phase
- PHASE3
Insulin Resistance Associated With Chronic Hepatitis C (CHC) and the Effect of Antiviral Therapy
- Status
- UNKNOWN
- Phase
- NA
Neurocognitive Functioning in Patients With Hepatitis C Pre- and Post-Treatment With Antiviral Medication
- Status
- UNKNOWN
- Phase
- N/A